Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
New painkiller GRT7041 enters first human safety trial
Symptom relief Recruiting nowThis early-stage trial tests a new drug called GRT7041 for pain. It involves 70 healthy volunteers to check safety, side effects, and how the body processes the drug. The study is split into single and multiple dose parts, lasting up to 8 weeks. It is not yet testing the drug on …
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 17, 2026 06:52 UTC
-
Healthy men needed to track how experimental drug exits the body
Knowledge-focused Recruiting nowThis study looks at how a single dose of an experimental drug called GRT6019 is processed and removed from the body. Ten healthy men aged 30 to 65 will provide urine and stool samples to measure the drug's breakdown products. The goal is to understand the drug's metabolism, not t…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC